Skip to search.
 Dow Up 1.02% Nasdaq Up 0.74%
Endocyte, Inc. (ECYT)On Dec 23: 3.41  Up 0.06 (1.79%)  

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2011Jun 30, 2011Mar 31, 2011Dec 31, 2010
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development8,916  7,722  4,438  3,290  
Selling General and Administrative2,723  2,340  2,074  1,317  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (11,639) (10,062) (6,513) (4,607)
Income from Continuing Operations
Total Other Income/Expenses Net18  33  22  1,653  
Earnings Before Interest And Taxes(11,621)(10,028)(6,491)(2,953)
Interest Expense449  491  698  394  
Income Before Tax(12,070)(10,519)(7,189)(3,348)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(12,070)(10,519)(7,189)(3,348)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (12,070) (10,519) (7,189) (3,348)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (12,070) (10,519) (7,189) (3,348)

Currency in USD.